BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32622856)

  • 1. FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological intervention.
    Annett S; Moore G; Robson T
    Pharmacol Ther; 2020 Nov; 215():107623. PubMed ID: 32622856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FKBP family proteins: immunophilins with versatile biological functions.
    Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
    Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506 binding proteins as targets in anticancer therapy.
    Romano S; Di Pace A; Sorrentino A; Bisogni R; Sivero L; Romano MF
    Anticancer Agents Med Chem; 2010 Nov; 10(9):651-6. PubMed ID: 21182472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of FKBP family protein: evaluation, structure, and function in mammals and Drosophila melanogaster.
    Ghartey-Kwansah G; Li Z; Feng R; Wang L; Zhou X; Chen FZ; Xu MM; Jones O; Mu Y; Chen S; Bryant J; Isaacs WB; Ma J; Xu X
    BMC Dev Biol; 2018 Mar; 18(1):7. PubMed ID: 29587629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506-Binding Proteins and Their Diverse Functions.
    Tong M; Jiang Y
    Curr Mol Pharmacol; 2015; 9(1):48-65. PubMed ID: 25986568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.
    Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G
    Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FKBP52.
    Davies TH; Sánchez ER
    Int J Biochem Cell Biol; 2005 Jan; 37(1):42-7. PubMed ID: 15381148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large FK506-binding proteins shape the pharmacology of rapamycin.
    März AM; Fabian AK; Kozany C; Bracher A; Hausch F
    Mol Cell Biol; 2013 Apr; 33(7):1357-67. PubMed ID: 23358420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium- and FK506-independent interaction between the immunophilin FKBP51 and calcineurin.
    Li TK; Baksh S; Cristillo AD; Bierer BE
    J Cell Biochem; 2002; 84(3):460-71. PubMed ID: 11813252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FKBP immunophilins and Alzheimer's disease: a chaperoned affair.
    Cao W; Konsolaki M
    J Biosci; 2011 Aug; 36(3):493-8. PubMed ID: 21799260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FKBPs and the Akt/mTOR pathway.
    Hausch F; Kozany C; Theodoropoulou M; Fabian AK
    Cell Cycle; 2013 Aug; 12(15):2366-70. PubMed ID: 23839048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities.
    Monaghan P; Bell A
    Mol Biochem Parasitol; 2005 Feb; 139(2):185-95. PubMed ID: 15664653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
    Navarro-Villarán E; de la Cruz-Ojeda P; Contreras L; González R; Negrete M; Rodríguez-Hernández MA; Marín-Gómez LM; Álamo-Martínez JM; Calvo A; Gómez-Bravo MA; de la Cruz J; Padillo J; Muntané J
    Cell Physiol Biochem; 2020 May; 54(3):457-473. PubMed ID: 32369692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506.
    Davies TH; Ning YM; Sánchez ER
    Biochemistry; 2005 Feb; 44(6):2030-8. PubMed ID: 15697228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.
    Bierer BE; Mattila PS; Standaert RF; Herzenberg LA; Burakoff SJ; Crabtree G; Schreiber SL
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9231-5. PubMed ID: 2123553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FK506-binding protein of the malaria parasite, Plasmodium falciparum, is a FK506-sensitive chaperone with FK506-independent calcineurin-inhibitory activity.
    Kumar R; Adams B; Musiyenko A; Shulyayeva O; Barik S
    Mol Biochem Parasitol; 2005 Jun; 141(2):163-73. PubMed ID: 15850699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into
    Rajan S; Yoon HS
    Front Cell Infect Microbiol; 2022; 12():931635. PubMed ID: 36118020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506 and rapamycin neuroprotect erection and involve different immunophilins in a rat model of cavernous nerve injury.
    Lagoda G; Sezen SF; Burnett AL
    J Sex Med; 2009 Jul; 6(7):1914-23. PubMed ID: 19453873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506.
    Xu X; Su B; Barndt RJ; Chen H; Xin H; Yan G; Chen L; Cheng D; Heitman J; Zhuang Y; Fleischer S; Shou W
    Transplantation; 2002 Jun; 73(11):1835-8. PubMed ID: 12085010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of FKBP associated protein 48 (FAP48) at proline 219 disrupts the interaction with FKBP12 and FKBP52.
    Neye H
    Regul Pept; 2001 Mar; 97(2-3):147-52. PubMed ID: 11164950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.